Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
Study: COVID-19 shots shown effective in cancer patients up to 4 months later - UPI.com
EX-99.1 2 f6k060319ex99-1_canfitebio.htm PRESS RELEASE DATED JUNE 3, 2019 Exhibit
Exclusive program launched for medical industry leaders - Globes
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Leadership – CTG-Pharma
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - Annals of Oncology
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Supplemental Materials for First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre ...
Prof. Naphtali Savion | Sackler Faculty of Medicine
First-of-its-kind study in Israel finds that cancer patients are safe for COVID-19 vaccines - EJP
More Data on COVID-19 Vaccination and Cancer | Cancer Today
Kimberly Lynn Blackwell, MD | medicine.duke.edu
Cancers | Special Issue : Hepatobiliary Cancers
COVID Booster May Benefit Active-Treatment Cancer Patients
Prof. Ruth Shalgi-Harsina | Sackler Faculty of Medicine
MD Anderson study finds ribociclib improves survival for women with metastatic breast cancer | MD Anderson Cancer Center
Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib - Annals of Oncology
Findings from Can-Fite's Phase II Liver Cancer Study were Presented at ASCO Annual Meeting Late-Breaking Session | Business Wire
Pharma - Mor Research Applications
Pharmaceuticals | Free Full-Text | Tumor-Targeted Fluorescent Proteinoid Nanocapsules Encapsulating Synergistic Drugs for Personalized Cancer Therapy
Posttraumatic Growth in Breast Cancer Survivors: Constructive and Illusory Aspects - Pat‐Horenczyk - 2015 - Journal of Traumatic Stress - Wiley Online Library
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
Transnational cancer research lab | Felsenstein Medical Research Center
COVID-fighting antibodies last 4+ months in 87% of cancer patients: Israeli MDs | The Times of Israel
Joelle Hallak - Associate Director, HEOR Real World Evidence (RWE) Analytics - AbbVie | LinkedIn
